Profile of Palliative Patients Undergoing Radiotherapy
Seema Devi1*, Abhishek Kumar2 and Raina Rana3
1Additional Professor, Department of Radiation Oncology, IGIMS, Patna, India
2PG 3rd Year, Department of Radiation Oncology, IGIMS, Patna, India
3PG 2nd Year, Department of Radiation Oncology, IGIMS, Patna, India
*Corresponding Author: Seema Devi, Additional Professor, Department of Radiation Oncology, IGIMS, Patna, Bihar, India.
August 17, 2023; Published: August 31, 2023
Introduction: Palliative Care is an approach that improves the quality of life of the Patients and their families facing the problem associated with life threatening illness through the prevention and relief of symptoms by means of early identification and impeccable assessment and treatment of Pain and associated problem, physically psychologically and spiritually. Radiotherapy has a role in Palliative to relieve pain and other symptoms. It is a time efficient, well tolerated, successful, cost-effective treatment for oncology palliative care.
Materials and Methods: This study is an Institutional based randomized study conducted at Radiation Oncology Department in State Cancer Institute Indira Gandhi Institute of Medical Science, Patna, Bihar.
Result: A total of 293 patients were included in this study. Patients who received radiotherapy at our Institute from Jan 2022 to Jan 2023 were included and analysed, carcinoma lung was commonest in the males and carcinoma breast was the commonest in the females.
Conclusion: In the advance stage of cancer, palliative radiotherapy can provide effective, symptomatic relief with the less side effects.
Keywords: Palliative Care; Palliative Radiotherapy; Carcinoma
- Kapoor A., et al. “Analysis of patterns of palliative radiotherapy in North West India: A regional cancer center experience”. The Indian Journal of Palliative Care 21 (2015): 168-173.
- Lutz ST., et al. “Role of radiation therapy in palliative care of the patient with cancer”. Journal of Clinical Oncology 32 (2014): 2913-2919.
- Bourgier C., et al. “What type of hypofractionated radiotherapy of primary tumors in palliative care?” Cancer Radiotherapy 19 (2015): 442-445.
- Van Oorschot B., et al. “Palliative adiotherapy- New Approaches”. Seminars in Oncology 38 (2011): 443-449.
- Nayan Navin., et al. Clinical Profile of Cancer Patients of North East India Receiving Single Fraction Palliative Radiotherapy: A Study from Regional Cancer Centre Authors' affiliation (2019).
- Jones JA and Simone CB. “Palliative radiotherapy for advanced malignancies in a changing oncologic landscape: Guiding principles and practice implementation”. Annals of Palliative Medicine 3 (2014): 192-202.
- Holt TR and Yau VK. “Innovative program for palliative radiotherapy in Austrailia”. Journal of Medical Imaging and Radiation Oncology 54 (2010): 76-81.
- Sharma S., et al. “Palliative radiotherapy: Current status and future directions”. Seminars in Oncology 41 (2014): 751-763.
- Trivedi NP., et al. “Head and neck cancer in India: Need to formulate uniform national treatment guideline?” Indian Journal of Cancer 49 (2012): 6-10.
- Yeole BB., et al. “Survival from head and neck cancer in Mumbai (Bombay), India”. Cancer 89 (2000): 437-444.
- Carvalho AL., et al. “A comparison of radiotherapy or radiochemotherapy with symptomatic treatment alone in patients with advanced head and neck carcinomas”. European Archives of Oto-Rhino-Laryngology 257 (2000): 164-167.
- Agrawal JP., et al. “Hypofractionated, palliative radiotherapy for advanced head and neck cancer”. Radiotherapy and Oncology 89 (2008): 51-56.
- Singhal K., et al. “Pattern of Palliative care, Pain management and referral trends in patients receiving radiotherapy at a tertiary cancer center”. Indian Journal of Palliative Care 15 (2009): 148-154.
- Van Oorschot B., et al. “Palliative radiotherapy-New approaches”. Seminars in Oncology 38 (2011): 443-449.
- Polascik TJ and Mouraviev V. “Zoledronic acid in the management of metastatic bone disease”. Therapeutics and Clinical Risk Management 1 (2008): 261-268.
- Weinfurt KP., et al. “The Significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer”. Annals of Oncology 4 (2005): 579-584.
- Shibata J., et al. “Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology”. ESMO Open 2 (2016): e000037.
- Hernandez RK., et al. “Incidence of bone metastases in patients with solid tumors: analysis of oncology lectronic medical records in the United States”. BMC Cancer 1 (2018): 44.
- Coleman RE. “Skeletal complications of malignancy”. Cancer8 (1997): 1588-1594.
- Wood SL and Brown JE. “Personal medicine and bone metastases:Biomarkers, micro-RNAs and bone metastases”. Cancers 8 (82020: 2109.
- Rawla P. “Epidemiology of prostate cancer”. World Journal of Clinical Oncology 2 (2019): 63-89.
- Norgaard M., et al. “Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007)”. The Journal of Urology 1 (2010): 162-167.
- Brown JE., et al. “Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors”. Journal of the National Cancer Institute 1 (2005): 59-69.
- Coleman R. “Metastatic bone disease: clinical features, pathophysiology and treatment strategies”. Cancer Treatment Reviews 27 (2001): 165-176.
- Berenson J., et al. “Managing bone complications of solid tumors”. Cancer Biology and Therapy 5 (2006): 1086-1089.
- Tsuya A., et al. “Skeletal metastases in non small cell lung cancer: a retrospective study”. Lung Cancer 57 (2007): 229-232.
- Sugiura H., et al. “Predictors of survival in patients with bone metastasis of Lung Cancer”. Clinical Orthopaedics and Related Research 466 (2008): 729-736.
- Kosteva J and Langer C. “The Changing landscape of medical management of skeletal metastases in nonsmall cell lung cancer”. Current Opinion in Oncology 20 (2008): 155-161.
- Ripamonti C and Fulfaro F. “Malignant bone pain; pathophysiology and treatments”. Current Review of Pain 3 (2010): 187-196.
- Ripamonti U. “Smart biomaterials with intrinsic osteoinductivity: geometric control of bone differentiation”. In Bone Engineering (edition. JE Davis) (2000): 215-222.
- Fallon M. “Neuropathic pain in cancer”. British Journal of Anaesthesia 111 (2013): 105-111.
- Schouten L., et al. “Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma”. Cancer 94 (2002): 2698-2705.
- Castrucci W and Knisely J. “An update on the treatment of CNS metastases in small cell lung cancer”. Journal of Cancer 14 (2008): 138-146.
- A Soni., et al. “Breast cancer subtypes predispose the site of distant metastases”. American Journal of Clinical Pathology 4 (2015): 471-478.
- UY Arslan., et al. “Breast Cancer subtypes and outcomes of central nervous system metastases”. The Breast 6 (2011): 562-567.
- IJ Fidler. “The biology of brain metastases: challenges for therapy”. The Cancer Journal 4 (2015): 284-293.
- Westhoff PG., et al. “Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone me- tastases: A multicenter double blind placebo controlled randomized trial”. BMC Cancer 14 (2014): 347.
- Feyer PC and Steingraeber M. “Radiotherapy of bone metastasis in breast cancer patients-Current approaches”. Breast Care 7 (2012): 108-112.
- Akhtar MS., et al. “Quality of life and symptoms control in brain metastasis after palliative whole brain radiotherapy using two different protocols”. Journal of College of Physicians and Surgeons Pakistan 22 (2012): 311-316.
- Souchon R., et al. “DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer: Bone metastases and metastatic spinal cord compression (MSCC)”. Strahlentherapie und Onkologie 185 (2009): 417-424.